medigraphic.com

2007, Number S3

Arch Cardiol Mex 2007; 77 (S3)

Guides and recommendations for the use of contrast echocardiography. Latin American Forum of Contrast Echocardiography. Facultad de Ciencias Médicas. Departamento de Postgrado. Universidad Nacional de la Plata. Argentina

Boskis M, Corneli D, Cuenca G, Gutiérrez FP, Mathias JW, Morcerf F, Pinto SM, Pizzano N, Revilla H

Language: Spanish
References: 43
Page: 5-24
PDF size: 165.58 Kb.


Text Extraction

No abstract


REFERENCES

  1. PORTER TR, XIE F, KILZER K, DELIGONUL U: Detection of myocardial perfusion abnormalities during dobutamine and adenosine stress echocardiography with transient myocardial contrast imaging after minute quantities of intravenous perfluorbon exposed sonicated dextrose albumin. J Am Soc Echocardiogr 1996; 9(6): 779-786.

  2. PORTER TR, LI S, KRICSFELD D, ARMBRUSTER RW: Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J Am Coll Cardiol 1997; 29(4): 791-799.

  3. PORTER TR, LI S, OSTER R, DELIGONU U: The clinical implications of no Reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of thrombolisis in myocardial infarction TIMI 3 flow in patients with acute myocardial infarction. Am J Cardiol 1998; 82: 1173-1177.

  4. PORTER TR, LI S, JIANG L, GRAYBURN P, DELIGONUL U: Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographyc contrast and accelerated intermittent harmonic imaging. J Am Soc Echocardiogr 1999; 12(4): 266-271.

  5. BECHER H, TIEMANN K, SCHLIEF R, LÜDERITZ B, NANDA N: Harmonic power Doppler contrast echocardiography: Preliminary clinical results. Echocardiography 1997; 14(6): 637-642.

  6. HOFFMANN R, LETHEN H, MARXICK T, AMESE M, FIORETI P, PIGNITORE A, PICANO E, BUCK T, ERBEL R, FLACHSKAMPF FA, HANRATH PJ: Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiogram. Am Coll Cardiol 1996; 27(2): 330-6.

  7. MAIN ML, GRAYBURN PA: Clinical applications of transpulmonary contrast echocardiography. Am Heart J 1999; 137: 144.

  8. KAUL S, SENIOR R, DITRICH H, RAVAL U, KHATTAR R, LAHIRI A: Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99 Tc sesta MIBI single photon emission computed tomography. Circulation 1997; 96: 785-792.

  9. RINKEVICH D, KAUL S, WANG XQ, TONG KL, BELCIK T, KALVAITIS S, LEPPER W, DENT J, WEI K: Regional left ventricular perfusion and function in patients presenting to the emergency department with chest pain and no ST segment elevation. Eur Heart Journal 2005; 26: 1606-1611.

  10. KOROSOGLOU G, LABADZE N, HANSEN A, SELTER C, GIANNITSIS E, KATUS H, KUECHERER H: Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. Am J Cardiol 2004; 94: 1225-31.

  11. CALDAS MA, TSUTSUI JM, KOWATSCH I, ANDRADE JL, NICOLAU JC, RAMIRES JF, MATHIAS W, ET AL: J Value of myocardial contrast echocardiography for predicting left ventricular remodeling and segmental functional recovery after anterior wall acute myocardial infarction. J Am Soc Echocardiogr 2004; 17: 923-932.

  12. HILLIS GS, MULVAGH SL, PELLIKA P, HAGEN, MUNDA M, HAGEN ME, WRIGHT S, OH JK: Comparison of intravenous myocardial contrast echocardiography and low dose dobutamine echocardiography for predicting left ventricular functional recovery following acute myocardial infarction. Am J Cardiol 2003; 92: 504-508.

  13. TSUTSUI J, ELHENDY A, ANDERSON JR, XIE F, MC GRAIN A, PORTER TR: Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005; 112: 1444-1450.

  14. MATHIAS W, TSUTSUI J, ANDRADE J, KOWASH I, LEMOS P, LEAL S, KHANDERIA B, RAMIRES J: Value of rapid B Bloquers injection at peak dobutamine–atropine stress echocardiography for detection of coronary artery disease. J Am Coll Cardiol 2003; 41: 1583-1589.

  15. KAUL S, ITO H: Microvasculature in acute myocardial ischemia: Part I. Evolving concepts in patophysiology, Diagnosis and Treatment. Circulation 2004; 109: 146-149.

  16. MORCERF F, MORAES A, CARRINHO M, DOHMANN HJ: Study of coronary flow reserve with intravenous use of microbubbles (contrast echocardiography) and adenosine: protocol for clinical application in patients suspected of having coronary heart disease. Arq Bras Cardiol 2002; 78(3): 281-98.

  17. CARRINHO M, MORAES A, MORCERF F, MEDEIROS C, CASTIER M, ROMEO LJ: Myocardial contrast echocardiography in patients with suspected or known coronary artery disease: comparison with myocardial nuclear scintigraphy. Arq Bras Cardiol 2004; 83(5): 419-23.

  18. RONDEROS RE, BOSKIS M, CHUNG N, CORNELI DB, ESCUDERO EM, HA JW, CHARLANTE C, RIM S, PORTIS M, FABRIS N, CAMILLETTI J, MELE A, OTERO F, PORTER T: Correlation between myocardial perfusion abnormalities detected with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high-dose dipyridamole stress echo. Clin Cardiol 2002; 25: 103-111.

  19. DAWSON D, RINKEVICH D, BELCIK T, JAYAWEERA AR, RAFTER P, KAUL S, WEI K: Measurement of myocardial blood flow velocity reserve with myocardial contrast echocardiography in patients with suspected coronary artery disease: comparison with quantitative gated Technetium 99m sestamibi single photon emission computed tomography. J Am Soc Echocardiogr 2003; 16(11): 1171-7.

  20. PELTIER M, VANCRAEYNEST D, PASQUET A, AY T, ROELANTS V, D’HONDT AM, MELIN JA, VANOVERSCHELDE JL: Assessment of the physiologic significance of coronary disease by dipyridamole real time myocardial contrast echocardiography. J Am Coll Cardiol 2004; 43(2): 257-64.

  21. WEI K, CROUSE L, WEISS J, VILLANUEVA F, SCHILLER NB, NAQVI TZ, SIEGEL R, MONAGHAN M, GOLDMAN J, AGGARWAL P, FEIGENBAUM H, DEMARIA A: Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial results). Am J Cardiol 2003; 91(11): 1293-8.

  22. SENIOR R, LEPPER W, PASQUET A, CHUNG G, HOFFMAN R, VANOVERSCHELDE JL, CERQUEIRA M, KAUL S: Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. Am Heart J 2004; 147(6): 1100.

  23. JANARDHANAN R, SENIOR R: Accuracy of Dipyridamole myocardial contrast echocardiography for the detection of residual stenosis of the infarct related artery and multivessel disease early after acute myocardial infarction. J Am Coll Cardiol 2004; 43(12): 2247-52.

  24. ORABY MA, HAYS J, MAKLADY FA, EL-HAWARY AA, YANEZA LO, ZABALGOITIA M: Comparison of real-time coherent contrast imaging to dipyridamole thallium-201 single-photon emission computed tomography for assessment of myocardial perfusion and left ventricular wall motion. Am J Cardiol 2002; 90(5): 449-54.

  25. YU EH, SKYBA DM, LEONG-POI H, SLOGGETT C, JAMORSKI M, GARG R, IWANOCHKO RM, SIU SC: Incremental value of parametric quantitative assessment of myocardial perfusion by triggered Low-Power myocardial contrast echocardiography. J Am Coll Cardiol 2004; 43(10): 1807-13.

  26. SICARI R, RIPOLI A, PICANO E, DI GIOVANBATTISTA R, MINARDI G, AMBATIELLO S, PULIGNANO G, ACCARINO M, LUSA AM, DEL ROSSO G, PEDRINELI R: Preoperative prognostic value of dipyridamole echocardiography in vascular surgery A large scale multicenter study in 509 patients EPIC study group. Circulation 1999; 100( 19 suppl): II269-274.

  27. PIGNITORE A, PICANO E, VARGA A, GIGLI G, CORTIGIANI L, PREVITALI M, MINARDI G, COLOSSO MO, LOWENSTEIN J, MATHIAS W JR: Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease a prospective, large scale, multicenter head to head comparison between dipyridamole and dobutamine tests Echo persantine international cooperative ( EPIC) EDIC study groups. J Am Coll Cardiol 1999; 15: 34, 1769-1777.

  28. TSUTSUI J, OSORIO AF, LARIO FA, FERNANDES DF, SODRE G, ANDRADE JL, RAMIRES JA, MATHIAS W: Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echo cardiography with the conventional protocol. Am J Cardiol 2004; 94(11): 1367-1372.

  29. TSUTSUI J, ELHENDY A, XIE F, O’LEHARY A, MC GRAIN A, PORTER TR: Safety of dobutamine stress real time myocardial contrast echocardiography. J Am Coll Cardiol 2005; 45: 235-242.

  30. TSUTSUI J, XIE F, O’LEARY E, ELHENDY A, ANDERSON J, MC GRAIN A, PORTER TR: Diagnostic accuracy of dobutamine stress myocardial contrast echocardiography in patients with suspected acute coronary syndromes. Echocardiography 2005; 22: 487-95.

  31. ELHENDY A, O’LEARY EL, XIE F, MCGRAIN AC, ANDERSON JR, PORTER TR: Comparative accuracy of real time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 2004; 44(11): 2185-91.

  32. OLSZOWSKA M, KOSTKIEWICZ M, TRACZ W, PRZEWLOCKI T: Assessment of myocardial perfusion in patients with coronary artery disease. Comparison of myocardial contrast echocardiography and 99mTc MIBI single photon emission computed tomography. Int J Cardiol 2003; 90(1): 49-55.

  33. SHIMONI S, ZOGHBI WA, XIE F, KRICSFELD D, ISKANDER S, GOBAR L, MIKATI IA, ABUKHALIL J, VERANI MS, O’LEARY EL, PORTER TR: Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography. J Am Coll Cardiol 2001; 37(3): 741-747.

  34. LINDNER JR, VILLANUEVA F, DENT JM, WEI K, KAUL S: Assessment of resting perfusion with myocardial contrast echocardiography: Theoretical and practical considerations. Am Heart J 200; 139: 231-240.

  35. WEI K, RAGOSTA M, THORPE J, COGGINS M, MOSS S, KAUL S: Noninvasive quantification of coronary blood flow reserve using myocardial contrast echocardiography. Circulation 2001; 103: 2560-2565.

  36. KAUL S: Myocardial contrast echocardiography. 15 years of research and developement. Circulation 1997; 96: 3745-3760.

  37. KAUL S, JAWAWEERA AR: Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? Circulation 1997; 96: 719-724.

  38. VAN CAMP G, AY T, PASQUET A, LONDON V, BOL A, GISELLU G, HENDRICKX G, RAFTER P, MELIN JA, VANOVERSCHELDE JL: Quantification of myocardial blood flow and assessment of its transmural distribution with real-time power modulation myocardial contrast echocardiography. J Am Soc Echocardiogr 2003; 16(3): 263-70.

  39. YANO E, ITO H, IWAKURA K, KIMURA R, TANAKA K, OKAMURA A, KAWANO S, MASUYAMA T, FUJY K: Comparisons of myocardial contrast intensity and calilbrated CI among normal, kinetic and akinetic segments. J Am Coll Cardiol 2004; 43(10):1799-1806.

  40. MASUGATA H, PETERS B, LAFITTE S, STRACHAN GM, OHMORI K, DEMARIA AN: Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refilling curves. J Am Coll Cardiol 2001; 37(1): 262-9.

  41. GRAYBURN P: Stress echo without stress. Detection of coronary stenosis at rest by myocardial contrast echocardiography. Circulation 2005; 112: 1085- 1087.

  42. SHAW L, MONAGHAN M, NIHOYANNOPOLOUS P: Clinical and economical outcomes with myocardial contrast echocardiography. Heart 1999; 82: 16-21.

  43. SHAW L, GUILLAM L, FEINSTEIN S, DENT J, PLOTNICK G for the Optison multicenter study group. Use of intravenous contrast agent (Optison ®) to enhance echocardiography: Efficacy and cost implications. Am J Man Care 1998; 4: SP169-SP176.




2020     |     www.medigraphic.com